Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids

The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Search result: 0

Kekelidze Z.I.

Serbsky Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russia

Klimenko T.V.

Serbsky Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russia;
Russian State University of Justice, Moscow, Russia

Kozlov A.A.

Kafedra i klinika fakul'tetskoĭ khirurgii, kafedra obshcheĭ i klinicheskoĭ patologii Samarskogo gosudarstvennogo meditsinskogo universiteta, Samarskaia GKB #1 im. N.I. Pirogova

Shakhova S.M.

Moscow Research and Practical Centre for Narcology of the Department of Public Health of Moscow, Moscow, Russia;
Sechenov First Moscow State Medical University, Moscow, Russia

Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids

Authors:

Kekelidze Z.I., Klimenko T.V., Kozlov A.A., Shakhova S.M.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(12): 21‑26

DOI: 10.17116/jnevro201711712121-26

Views: 947

Downloaded: 12

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Kekelidze ZI, Klimenko TV, Kozlov AA, Shakhova SM. Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(12):21‑26. (In Russ.)
https://doi.org/10.17116/jnevro201711712121-26

Close metadata

Based on the study of 43 patients with acute psychosis due to the use of synthetic cannabinoids, the authors showed that the inclusion of neuroleptic drugs in the complex therapy increases the efficacy of therapy. In choosing a neuroleptic it is important to take into account not only the psychopathological structure of psychosis, but also the severity of somatic and neurological disorders associated with psychosis.

Keywords:

new psychoactive substances

synthetic cannabinoids

spice

psychosis

Authors:

Kekelidze Z.I.

Serbsky Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russia

Klimenko T.V.

Serbsky Federal Medical Research Center for Psychiatry and Narcology, Moscow, Russia;
Russian State University of Justice, Moscow, Russia

Kozlov A.A.

Kafedra i klinika fakul'tetskoĭ khirurgii, kafedra obshcheĭ i klinicheskoĭ patologii Samarskogo gosudarstvennogo meditsinskogo universiteta, Samarskaia GKB #1 im. N.I. Pirogova

Shakhova S.M.

Moscow Research and Practical Centre for Narcology of the Department of Public Health of Moscow, Moscow, Russia;
Sechenov First Moscow State Medical University, Moscow, Russia

List of references:

Vsemirnyi doklad o narkotikakh. 2016. Accessed May 10, 2017. (In Russ.) http://www.unodc.org/doc/wdr2016/WDR_2016_ExSum_russian.pdf
National Institute on Drug Abuse. DrugFacts: K2/Spice («Synthetic Marijuana»). Accessed May 10, 2017. (In Russ.) https://www.drugabuse.gov/drugs-abuse/synthetic-cannabinoids-k2spice
European Monitoring Centre for Drugs and Drug Addiction. Synthetic cannabinoids and «Spice» profile. Accessed May 10, 2017. (In Russ.) http://www.emcdda.europa.eu/publications/drug-profiles/synthetic-cannabinoids
Bokhan NA, Selivanov GYu. Klinicheskaya tipologiya psikhopatologicheskikh rasstroistv u potrebitelei sinteticheskikh kannabinoidov (spaisov). Sibirskii vestnik psikhiatrii i narkologii. 2015;4(89):18-23. (In Russ.)
Fattore L. Synthetic Cannabinoids — Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis. Biological Psychiatry. 2016;79:539-548.
Bondar’ IV, Nadezhdin AV, Vyazovichenko YuE, Simonov DV, Vishnyakov DA. Ob aktual’nosti problemy kuritel’nykh smesei (spaisov) na sovremennom etape. Sbornik materialov Vserossiiskoi nauchno-prakticheskoi konferentsii «Protivodeistvie nezakonnomu oborotu narkoticheskikh sredstv, psikhotropnykh veshchestv, ikh analogov i prekursorov v sovremennoi rossii: ugolovno-pravovoi i kriminologicheskii aspekty». Pod obshch. red. Batyrshina I.I. M.: FKU NITs FSKN Rossii; 2015;27-32. (In Russ.)
Savchuk SA. Obnaruzhenie sinteticheskikh kannabimimetikov, narkoticheskikh, psikhoaktivnykh veshchestv i ikh metabolitov v moche, volosakh i nogtyakh metodami zhidkostnoi khromatografii s mass-spektrometricheskim detektirovaniem. Informatsionnoe pis’mo. Narkologiya. 2014;8:42-52. (In Russ.)
Klimenko ТV, Shakhova SМ, Kozlov AA. Psychotic disorders after use of synthetic cannabinoids (spice). Siberian herald of Psychiatry and Addiction Psychiatry. 2017;2(95):25-29. (In Russ.)
Bazire S. Risperidone in schizophrenia. The British Journal of Psychiatry. 1996;168(1):128. https://doi.org/10.1192/bjp.168.1.128a
Belousov YuB, Moiseev VS, Lepakhin VK. Klinicheskaya farmakologiya i farmakoterapiya. Rukovodstvo dlya vrachei. 2-e izd. ispr. i dop. M.: Universum publishing; 1997. (In Russ.)

Close metadata

Log in to the site using your account in one of the services

Registration

Last Name

Name

Middle Name

E-mail

Phone

Address

Country

Zip

City

Region

Street

Home

Apartmen

Legal entity name

ИНН

КПП

Password

Password

Repeat password

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.